Exact Mass: 556.1515

Niceritrol

C29H24N4O8 (556.1594)

C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AD - Nicotinic acid and derivatives C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites

4-O-(3-O-methyl-beta-D-glucopyranosyl)-diphyllin

C28H28O12 (556.1581)

Didmolamide B

C25H28N6O5S2 (556.1563)

Epicatechin 5-O-beta-D-glucopyranoside-3-benzoate

C28H28O12 (556.1581)

1748-04-5

C30H24N2O9 (556.1482)

C28H28O12

C28H28O12 (556.1581)

7-[(O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl)oxy]methyl-4-hydroxy-5H-furo[3,2-g][1]benzopyran-5-one

C24H28O15 (556.1428)

yunnaneic acid J

C28H28O12 (556.1581)

4-O-(2,3-O-diacetyl-6-O-p-coumaroyl-beta-D-glucopyranosyl)-p-coumaric acid

C28H28O12 (556.1581)

Iresinoside

C28H28O12 (556.1581)

NSC291931

C29H24N4O8 (556.1594)

C24H28O15

C24H28O15 (556.1428)

aloenin 2-p-coumaroyl ester|aloenin-2-p-coumaroyl ester|p-coumaroyl aloenin

C28H28O12 (556.1581)

desoxyrhaponticin 6-O-gallate

C28H28O12 (556.1581)

Niceritrol

C29H24N4O8 (556.1594)

C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AD - Nicotinic acid and derivatives C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites

o-cresolsulfonphthalein-3,3-bis(methylaminoacetic acid sodium salt)

C27H28N2O9S (556.1515)

Uridine,2,3,5-tribenzoate

C30H24N2O9 (556.1482)

2-Carboxybenzoyl Amlodipine

C28H29ClN2O8 (556.1612)

dCpdG

C19H25N8O10P (556.1431)

Deoxycytidylyl-3,5-guanosine

C19H25N8O10P (556.1431)

7,13-Bis[(2-chloro-4-nitrophenyl)methyl]-1,4,10-trioxa-7,13-diazacyclopentadecane

C24H30Cl2N4O7 (556.1491)

Epicatechin 5-O-beta-D-glucoside-3-benzoate

C28H28O12 (556.1581)

9-(2h-1,3-benzodioxol-5-yl)-4-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy}-6,7-dimethoxy-3h-naphtho[2,3-c]furan-1-one

C28H28O12 (556.1581)

(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[5-hydroxy-2-(4-methoxy-6-oxopyran-2-yl)-3-methylphenoxy]-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C28H28O12 (556.1581)

(5r,6s)-6-{[(2s,3r,4s,5s,6r)-3-{[1,1'-biphenyl]-3,3',5-triyloxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-ethenyl-3h,5h,6h-pyrano[3,4-c]pyran-1-one

C28H28O12 (556.1581)

(2r,3r)-2-(3,4-dihydroxyphenyl)-7-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-3-yl benzoate

C28H28O12 (556.1581)

(2s,3s)-2-(3,4-dihydroxyphenyl)-7-hydroxy-5-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-3-yl benzoate

C28H28O12 (556.1581)

4,5-dihydroxy-2-[5-hydroxy-2-(4-methoxy-6-oxopyran-2-yl)-3-methylphenoxy]-6-(hydroxymethyl)oxan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C28H28O12 (556.1581)

amaronitidin

C28H28O12 (556.1581)

{"Ingredient_id": "HBIN015819","Ingredient_name": "amaronitidin","Alias": "NA","Ingredient_formula": "C28H28O12","Ingredient_Smile": "C=CC1C(OC=C2C1=CCOC2=O)OC3C(C(C(C(O3)CO)O)O)OC4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O","Ingredient_weight": "556.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1019","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101720810","DrugBank_id": "NA"}

9-(2h-1,3-benzodioxol-5-yl)-4-{[3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy}-6,7-dimethoxy-3h-naphtho[2,3-c]furan-1-one

C28H28O12 (556.1581)

(7r)-5-bromo-3-(2-hydroxy-6-methylphenyl)-7-methyl-6,8-dioxoisochromen-7-yl (2e,4s)-2,4-dimethyldec-2-enoate

C29H33BrO6 (556.146)

7-[(4-carboxy-2,5-dihydroxybenzoyloxy)methyl]-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C24H28O15 (556.1428)

(1r,4ar,7r,7ar)-7-[(4-carboxy-2,5-dihydroxybenzoyloxy)methyl]-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C24H28O15 (556.1428)

(11s,14s)-11-benzyl-14-(1-hydroxyethyl)-4,17-dimethyl-6,19-dithia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H28N6O5S2 (556.1563)

(4r,11s,14s,17r)-11-benzyl-14-[(1r)-1-hydroxyethyl]-4,17-dimethyl-6,19-dithia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H28N6O5S2 (556.1563)

4-hydroxy-7-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)furo[3,2-g]chromen-5-one

C24H28O15 (556.1428)

5-bromo-3-(2-hydroxy-6-methylphenyl)-7-methyl-6,8-dioxoisochromen-7-yl 2,4-dimethyldec-2-enoate

C29H33BrO6 (556.146)

4-hydroxy-7-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)furo[3,2-g]chromen-5-one

C24H28O15 (556.1428)

(11s,14s)-11-benzyl-14-[(1r)-1-hydroxyethyl]-4,17-dimethyl-6,19-dithia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H28N6O5S2 (556.1563)

11-benzyl-14-(1-hydroxyethyl)-4,17-dimethyl-6,19-dithia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H28N6O5S2 (556.1563)

2-(3,4-dihydroxyphenyl)-7-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-3-yl benzoate

C28H28O12 (556.1581)

3-(4-hydroxyphenyl)-3-{6-[(1z)-2-(4-hydroxyphenyl)ethenyl]-2-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-3-yl}propanoic acid

C28H28O12 (556.1581)

(4s,11s,14s,17s)-11-benzyl-14-[(1r)-1-hydroxyethyl]-4,17-dimethyl-6,19-dithia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H28N6O5S2 (556.1563)